Search results
Results From The WOW.Com Content Network
A legal battle between rival developers of Covid-19 jabs over life-saving vaccine technology patents has produced a mixed ruling from a High Court judge.
At Wednesday’s hearing, the same judge granted Pfizer and BioNTech permission to appeal against his EP949 decision, but refused Moderna permission to appeal against his ruling over the EP565 patent.
The High Court gave a mixed ruling in July, ruling that one of Moderna's two patents relating to the messenger RNA (mRNA) technology that underpinned its COVID-19 vaccine was invalid.
This is a list of notable patent law cases in the United States in chronological order. The cases have been decided notably by the United States Supreme Court, the United States Court of Appeals for the Federal Circuit (CAFC) or the Board of Patent Appeals and Interferences (BPAI). While the Federal Circuit (CAFC) sits below the Supreme Court ...
For the purpose of calculating damages in a patent infringement action, the infringing "article of manufacture" may be defined as either an end product sold to a consumer or as a component of that product. 35 U.S.C. §289: The relevant text of the Patent Act encompasses both an end product sold to a consumer as well as a component of that product.
LONDON (Reuters) -Pfizer and Moderna's legal battle over their rival COVID-19 vaccines looks set to continue after London's High Court gave a mixed ruling on two of Moderna's patents, likely ...
In light of the COVID-19 pandemic, several companies around the world raced to develop testing, vaccines, and cures for COVID-19. This required a substantial investment of time and money, and patents were used to protect this innovation. Patent holders are able to refuse licensing for third-parties to manufacture the patented medicine, creating ...
(Reuters) -Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and BioNTech.